Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma

Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma

Bibliographic Details
Main Authors:	Kaplan Lawrence D, Sparano Joseph A, Lee Jeannette Y, Barta Stefan K, Noy Ariela
Format:	Article
Language:	English
Published:	BMC 2010-10-01
Series:	Infectious Agents and Cancer

Similar Items

Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)
by: Egorin Merrill J, et al.
Published: (2010-10-01)

Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens
by: Zhang F, et al.
Published: (2019-08-01)

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
by: Kim Yu, et al.
Published: (2012-08-01)

Infusiones peruanas en máquinas expendedoras Wasinmanta
by: Arica Araujo de Valverde, Emma Alejandrina, et al.
Published: (2018)

Rituximab induced hypoglycemia in non-Hodgkin's lymphoma
by: Lali V, et al.
Published: (2006-12-01)

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
by: Koh Ki-Ryang, et al.
Published: (2009-08-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

Complete remission of primary bilateral adrenal lymphoma achieved by Rituximab-CHOP chemotherapy
by: Yang Yin-long, et al.
Published: (2011-12-01)

Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting
by: Clement D. Okello, et al.
Published: (2020-08-01)

Acute Cardiogenic Shock Induced by Infusional 5-Fluorouracil
by: Jeffrey Sulpher, et al.
Published: (2014-01-01)

Rituximab in the treatment of non-Hodgkin&rsquo;s lymphoma
by: Beate Hauptrock, et al.
Published: (2008-09-01)

Expanded use of rituximab in the management of non-Hodgkin lymphoma
by: Dennis A Eichenauer, et al.
Published: (2009-07-01)

CHOP-like Regimen in Combination with Rituximab and Peginterferon Alpha-2b in Newly-diagnosed Diffuse Large B-cell Non-Hodgkin’s Lymphoma: Experience in a Chinese Center
by: Shu-qing LV, Jian-min YANG, Xian-min SONG, Li CHEN, Wei-ping ZHANG, Xiao-qian XU, Xiong NI, Chong-mei HUANG, Yi HE, Jian-min WANG, et al.
Published: (2010-04-01)

Clinical and economic aspects of the use of rituximab in non-Hodgkin's lymphoma
by: Camila Bezerra Melo Figueirêdo, et al.
Published: (2014-09-01)

Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin’s lymphoma
by: Eva Fernández Cañabate, et al.
Published: (2018-01-01)

Modified EPOCH for high‐risk non‐Hodgkin lymphoma in sub‐Saharan Africa
by: Takondwa Zuze, et al.
Published: (2020-01-01)

Terapia infusional por cateteres venosos periféricos em idosos hospitalizados
by: Vieira, Gilson de Bitencourt
Published: (2017)

Artea Infusiones - Frutos nativos andinos y de la amazonia
by: Corzo Callirgos, Marco Antonio, et al.
Published: (2021)

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
by: Myrna Candelaria, et al.
Published: (2021-01-01)

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma
by: K. Lisenko, et al.
Published: (2017-05-01)

Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice
by: Thais Bascuas, et al.
Published: (2018-01-01)

CHOP THERAPY INDUCED MITOCHONDRIAL REDOX STATE ALTERATION IN NON-HODGKIN'S LYMPHOMA XENOGRAFTS
by: H. N. XU, et al.
Published: (2013-04-01)

The AMC Mechanism in Taiwan
by: 張敏郎
Published: (2001)

Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study
by: Ma Q, et al.
Published: (2019-02-01)

Aggressive Non-Hodgkin's Lymphoma: therapeutic considerations of pre rituximab era
by: Carmino Antônio de Souza
Published: (2005-10-01)

Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas
by: Claudio Fozza, et al.
Published: (2011-01-01)

Fattori Metabolici Nella Risposta Renale All'infusione Di Amino Acidi
by: A. Claris-Appiani, et al.
Published: (1999-01-01)

Incidência de flebite e flebite pós-infusional em adultos hospitalizados
by: Janete de Souza Urbanetto, et al.
Published: (2017-06-01)

Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
by: Belinda A. Di Bartolo, et al.
Published: (2016-06-01)

Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control design
by: Egorin Merrill J, et al.
Published: (2010-10-01)

CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.
by: Satish Gopal, et al.
Published: (2016-01-01)

Rituximab for primary cutaneous large B-cell non-Hodgkin's lymphoma of the scalp
by: Čolović Nataša, et al.
Published: (2008-01-01)

Linfoma não-Hodgkin difuso de grandes células B : características clínicas, tratamento e prognóstico com os esquemas quimioterápicos CHOP e CHOP-Bleo
by: Mota, Sandra Mara Brasileiro
Published: (2013)

Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
by: Unhee Lim, et al.
Published: (2014-01-01)

Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP
by: Kyoung Min Cho, et al.
Published: (2019-07-01)

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
by: Shinya Rai, et al.
Published: (2018-09-01)

Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
by: R. A. Golubenko, et al.
Published: (2014-07-01)

Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness
by: Firas Badin, et al.
Published: (2010-04-01)

Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
by: A Boland, et al.
Published: (2009-09-01)

Cannot write session to /tmp/vufind_sessions/sess_feo7hgohibg5tbae7jeucqvr91